138 related articles for article (PubMed ID: 18159129)
1. Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure.
Hodoshima N; Masuda S; Inui K
Drug Metab Pharmacokinet; 2007 Dec; 22(6):419-27. PubMed ID: 18159129
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats.
Hodoshima N; Nakano Y; Izumi M; Mitomi N; Nakamura Y; Aoki M; Gyobu A; Shibasaki S; Kurosawa T
Drug Metab Pharmacokinet; 2004 Feb; 19(1):68-75. PubMed ID: 15499172
[TBL] [Abstract][Full Text] [Related]
3. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
Konishi H; Morita Y; Mizumura M; Iga I; Nagai K
J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
6. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Ogino T; Inoue M; Okada S; Kinoshita H
Free Radic Res; 2003 Apr; 37(4):373-9. PubMed ID: 12747731
[TBL] [Abstract][Full Text] [Related]
7. Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice.
Takigawa M; Masutomi H; Kishimoto Y; Shimazaki Y; Hamano Y; Kondo Y; Arai T; Lee J; Ishii T; Mori Y; Ishigami A
Biol Pharm Bull; 2017; 40(7):975-983. PubMed ID: 28674262
[TBL] [Abstract][Full Text] [Related]
8. [Nephrotoxicity and drug interaction of vancomycin].
Toyoguchi T; Nakagawa Y; Watanabe H
Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
[TBL] [Abstract][Full Text] [Related]
9. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
Cetin H; Olgar S; Oktem F; Ciris M; Uz E; Aslan C; Ozguner F
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1181-5. PubMed ID: 17880374
[TBL] [Abstract][Full Text] [Related]
10. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A
Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176
[TBL] [Abstract][Full Text] [Related]
11. Effect of cilastatin on renal handling of vancomycin in rats.
Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
[TBL] [Abstract][Full Text] [Related]
12. Anti-oxidant, anti-apoptotic, and mitochondrial regulatory effects of selenium nanoparticles against vancomycin induced nephrotoxicity in experimental rats.
Mehanna ET; Khalaf SS; Mesbah NM; Abo-Elmatty DM; Hafez MM
Life Sci; 2022 Jan; 288():120098. PubMed ID: 34715137
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of decreased renal function between patients treated with brand and generic products of vancomycin hydrochloride injection].
Izuwa Y; Ueshima S; Sato T; Okazaki M; Aiba T; Kawasaki H; Kurosaki Y; Sendo T
Yakugaku Zasshi; 2008 Oct; 128(10):1493-8. PubMed ID: 18827470
[TBL] [Abstract][Full Text] [Related]
14. [A study on nephrotoxicity of arbekacin and vancomycin in rats].
Niizato T; Ohnishi M; Nishiyama S; Asaoka H; Saito A
Jpn J Antibiot; 1994 Jun; 47(6):664-75. PubMed ID: 8072175
[TBL] [Abstract][Full Text] [Related]
15. Toxicity Profile and Pharmacokinetic Study of Antibiotic Mixtures, Gentamicin and Vancomycin, in Rat Plasma by Ecofriendly Liquid Chromatography Coupled Tandem Mass Spectrometry.
Ibrahim F; Elgawish MS; Mehana E; El-Adl SM; Baraka MM; Ibrahim SM; Sebaiy MM
Chem Res Toxicol; 2020 Oct; 33(10):2647-2658. PubMed ID: 32940458
[TBL] [Abstract][Full Text] [Related]
16. Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats.
Uckun Z; Guzel S; Canacankatan N; Yalaza C; Kibar D; Coskun Yilmaz B
Drug Chem Toxicol; 2020 Jan; 43(1):104-111. PubMed ID: 30257567
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats.
Basarslan F; Yilmaz N; Ates S; Ozgur T; Tutanc M; Motor VK; Arica V; Yilmaz C; Inci M; Buyukbas S
Hum Exp Toxicol; 2012 Jul; 31(7):726-33. PubMed ID: 22318306
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
[TBL] [Abstract][Full Text] [Related]
19. [Nephrotoxicity and drug interaction of vancomycin (2)].
Toyoguchi T; Nakagawa Y
Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
[TBL] [Abstract][Full Text] [Related]
20. Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
Yamamoto T; Terakawa H; Hisaka A; Suzuki H
J Pharm Sci; 2012 Aug; 101(8):2968-75. PubMed ID: 22570265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
